AMANDA MANLEY: Open Payments
NPI 1427541630 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 32 payments from 10 companies in 2025. Trend: 2023 $412 · 2024 $448 · 2025 $814
Food & beverage: $715Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $394 |
| Abbott Laboratories | 6 | $174 |
| SHIELD THERAPEUTICS INC | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $39 |
| MILLICENT US INC | 1 | $24 |
| Organon LLC | 1 | $20 |
| Biogen, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Hologic Sales and Service, LLC | 1 | $16 |
Products named: Veozah, FREESTYLE LIBRE 3, ACCRUFER, Mirena, INTRAROSA, NEXPLANON, ZURZUVAE, ZEPBOUND.
Industry payments across AR — which companies pay providers there.
